The Future of Veterinary Medicine: A Shift Toward More Personalized Therapies
Over the past year, working alongside veterinary software companies, pharmacy partners, practice groups, and industry leaders has given me a unique perspective on how innovation moves through animal health. One thing has become clear: veterinary medicine tends to adopt innovation thoughtfully rather than quickly.
New therapies, technologies, and workflows often take years to become mainstream, but once they do, they can fundamentally change how care is delivered.
We've seen that with digital prescribing, cloud-based practice management systems, online pharmacies, and the industry's gradual shift toward more connected technology. Electronic prescribing is a great example. What was once considered an emerging capability has become an expectation across much of human healthcare, and veterinary medicine continues moving in the same direction. As prescribing becomes more connected, the technology supporting it becomes just as important as the medications themselves.
Recently, another area of innovation caught my attention while following developments in human healthcare: peptide therapies.
While much of the momentum today is happening outside of veterinary medicine, it raised an interesting question.
Could this be another innovation that eventually influences how veterinarians diagnose, treat, and prescribe for their patients?
That question quickly led me to another.
As veterinary medicine continues to evolve, is the technology supporting veterinarians evolving with it?
Looking Beyond Peptides
The more I researched peptides, the more I realized this isn't really an article about peptides.
It's about where veterinary medicine is headed.
Researchers have been exploring more personalized treatment approaches, targeted therapies, and advances in companion animal medicine for years. Continued progress in diagnostics, specialty pharmaceuticals, and compounding has steadily expanded the treatment options available to veterinarians.
Whether peptide therapies ultimately become a significant part of veterinary medicine remains to be seen.
But the broader trend is already underway.
Veterinarians have more treatment options today than they did a decade ago, and there's every reason to believe that innovation will continue. As medicine evolves, veterinarians will have access to more specialized therapies, more treatment options, and more opportunities to tailor care to each individual patient.
For veterinarians, that creates exciting new possibilities—but it also introduces new complexity into the prescribing process.
Why Peptide Therapies Are Worth Watching
Among the innovations attracting attention today are peptide therapies, which have seen rapid growth in human healthcare because of their potential to target specific biological processes.
Veterinary medicine is still in the early stages of that conversation, but researchers are actively exploring peptide-based therapies for a variety of potential applications, including pain management, wound healing, dermatology, oncology, endocrine disorders, and immune-mediated diseases.
It's also important to understand where the industry stands today.
There are relatively few FDA-approved peptide-based medications developed specifically for veterinary use, and many peptide therapies remain investigational or may be compounded for specific clinical situations. As with any emerging therapeutic category, continued research, regulatory oversight, and evidence-based guidance will determine how these therapies evolve within veterinary medicine.
Whether peptide therapies ultimately become commonplace isn't really the point.
What makes them interesting is what they represent.
They're another example of how veterinary medicine continues expanding beyond traditional treatment options—and why veterinary prescribing technology needs to be ready as those options grow.
Innovation Doesn't Stop with the Medication
One thing I've come to appreciate working in veterinary technology is that every new therapy creates ripple effects across the entire industry.
When a pharmaceutical company introduces a new medication, that's only the beginning.
Pharmacies need to determine how they'll stock and dispense it.
Practice management systems need to support it.
Prescribing platforms need to recognize it.
Medication databases need to stay current.
Software vendors need to update formularies.
Practice teams need workflows that make prescribing simple, accurate, and efficient.
Innovation doesn't end when a medication reaches the market.
In many ways, that's where the real work begins.
The Growing Complexity of Veterinary Prescribing
Behind every prescription is an ecosystem most people never see.
Medication databases.
Pharmacy networks.
Compound formularies.
Specialty pharmacies.
State regulations.
Clinical workflows.
As treatment options continue expanding, so does the complexity behind every prescription.
That's not a problem.
It's a sign that veterinary medicine continues moving forward.
The challenge is making sure veterinarians never have to think about that complexity.
Their focus should remain exactly where it belongs—on selecting the best treatment for their patient.
Everything else should happen seamlessly in the background.
Why This Matters for VetWay
When we started building VetWay, we weren't simply thinking about today's prescribing challenges. We were thinking about where veterinary medicine will be five and ten years from now.
Our vision has never been to build another prescribing portal.
It's to build the infrastructure that allows veterinary prescribing to evolve alongside the industry itself.
As treatment options continue expanding, prescribing technology needs to be flexible enough to support growing formularies, compounded medications, specialty pharmacies, connected prescribing workflows, and future innovations.
Whether tomorrow's advancements involve peptide therapies, regenerative medicine, or something we haven't imagined yet, the challenge remains the same.
Veterinarians deserve technology that simplifies prescribing—not technology that adds another layer of complexity.
That means giving practices the flexibility to connect with the pharmacies they choose, supporting an expanding range of medications and treatment options, and making it easier for veterinarians to focus on patient care instead of administrative work.
That's the future we're building toward at VetWay.
Looking Ahead
One lesson has stood out to me over the past year.
Innovation doesn't create value on its own.
Value is created when an entire industry is prepared to support it.
That means researchers developing new therapies.
Pharmaceutical companies bringing those therapies to market.
Veterinarians adopting new treatment options.
Pharmacies expanding their capabilities.
Technology companies building the infrastructure that connects it all together.
Peptide therapies may or may not become a significant part of veterinary medicine.
That's not really the point.
They're simply one example of how medicine continues to evolve.
The real question isn't whether veterinary medicine will continue to innovate.
It will.
The question is whether the technology supporting veterinarians will evolve with it.
At VetWay, that's exactly the future we're building for.
Frequently Asked Questions
What are peptide therapies?
Peptide therapies are medications made from short chains of amino acids that interact with specific biological processes in the body. While peptide-based treatments have gained significant attention in human healthcare, their role in veterinary medicine is still emerging and continues to be studied across a variety of therapeutic areas.
Are peptide therapies approved for veterinary use?
There are relatively few FDA-approved peptide-based medications developed specifically for veterinary use today. Some peptide therapies are available through approved animal drugs, while others may be compounded or remain investigational. As with any treatment, veterinarians should evaluate available evidence, regulatory guidance, and each patient's individual needs.
What is personalized veterinary medicine?
Personalized veterinary medicine refers to tailoring treatment decisions to the individual patient rather than relying on a one-size-fits-all approach. As diagnostics, specialty pharmaceuticals, and therapeutic options continue to advance, veterinarians have more opportunities to select treatments based on a pet's specific condition and clinical needs.
How could personalized medicine change veterinary prescribing?
As treatment options expand, prescribing becomes more complex. Veterinarians may have access to additional formulations, specialty medications, compounded therapies, and pharmacy options. That makes connected veterinary prescribing technology increasingly important to help streamline workflows while maintaining accuracy and efficiency.
Why does prescribing technology matter as veterinary medicine evolves?
Every new medication or treatment option affects more than clinical care. Veterinary pharmacies, medication databases, prescribing platforms, and practice management systems all need to evolve to support new therapies. Modern digital prescribing technology helps reduce administrative complexity so veterinary teams can focus on patient care.
How is VetWay preparing for the future of veterinary prescribing?
VetWay was built with the understanding that veterinary medicine will continue to evolve. Our platform is designed to support expanding formularies, specialty pharmacies, compounded medications, connected prescribing, and future therapeutic innovations while providing veterinarians with a streamlined prescribing experience.